US Stock MarketDetailed Quotes

BCTX BriaCell Therapeutics

Watchlist
  • 2.110
  • -0.060-2.76%
Close May 1 16:00 ET
33.72MMarket Cap-2670P/E (TTM)

BriaCell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
(Q3)Apr 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
-99.17%-3.54M
-61.08%-12.48M
-70.91%-3.33M
13.67%-4.82M
Net income from continuing operations
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
-439.55%-10.02M
Operating gains losses
-79.21%1.59M
-246.84%-14.28M
-118.18%-2.12M
-7.73%-5.09M
-109.10%-539.43K
151.56%7.63M
-116.31%-4.12M
159.72%11.66M
-138.48%-4.73M
--5.93M
Depreciation and amortization
0.05%3.82K
0.00%3.82K
-0.01%15.27K
-0.03%3.82K
0.03%3.82K
-0.05%3.82K
0.03%3.82K
0.10%15.27K
0.16%3.82K
0.08%3.82K
Other non cash items
----
----
----
----
----
----
----
-100.13%-2.41K
--0
--0
Change In working capital
6,070.75%1.84M
-68.15%180.33K
-802.65%-3.53M
-507.17%-3.95M
88.66%-181.88K
-88.77%29.86K
2,664.38%566.19K
82.85%-391.29K
1,481.25%969.16K
40.92%-1.6M
-Change in receivables
-142.06%-8.74K
54.66%-2.54K
145.36%5.23K
58.45%-3.98K
-147.24%-5.97K
365.02%20.77K
17.17%-5.6K
-215.98%-11.53K
-396.71%-9.57K
215.15%12.63K
-Change in prepaid assets
-428.26%-1.03M
74.05%937.82K
-475.56%-4.4M
-1,179.51%-4.36M
35.52%-888.59K
212.99%312.73K
389.37%538.82K
-656.61%-764.05K
-24.66%403.94K
-116.29%-1.38M
-Change in payables and accrued expense
1,047.78%2.88M
-2,390.30%-754.95K
123.88%860.37K
-27.22%418.36K
398.37%712.68K
-274.72%-303.64K
126.28%32.96K
117.54%384.29K
220.23%574.8K
88.44%-238.86K
Cash from discontinued investing activities
Operating cash flow
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
-99.17%-3.54M
-61.08%-12.48M
-70.91%-3.33M
13.67%-4.82M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
0
0
205.65%3.95M
2,603.40%4M
-99.88%1.59K
0
-47.29K
-105.76%-3.74M
-100.42%-159.78K
-94.83%1.37M
Net common stock issuance
--0
--0
138.86%3.95M
3,996.09%4M
--0
--0
---47.29K
-119.70%-10.17M
-100.47%-102.67K
-100.04%-12.79K
Proceeds from stock option exercised by employees
----
----
-99.98%1.59K
--0
----
----
----
-52.50%6.51M
--0
1,801.30%1.38M
Net other financing activities
----
----
----
----
----
----
----
---80.69K
---57.12K
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
205.65%3.95M
2,603.40%4M
-99.88%1.59K
--0
---47.29K
-105.76%-3.74M
-100.42%-159.78K
-94.83%1.37M
Net cash flow
Beginning cash position
-63.56%13.65M
-48.22%21.25M
-28.33%41.04M
-36.74%28.17M
-30.18%33.5M
-32.51%37.45M
-28.33%41.04M
269,412.38%57.27M
121.92%44.53M
805,908.48%47.98M
Current changes in cash
-87.29%-7.4M
-111.86%-7.61M
-21.96%-19.79M
-98.51%-6.92M
-54.29%-5.33M
47.37%-3.95M
-101.83%-3.59M
-128.35%-16.23M
-109.59%-3.49M
-116.55%-3.45M
End cash Position
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-48.22%21.25M
-36.74%28.17M
-30.18%33.5M
-32.51%37.45M
-28.33%41.04M
-28.33%41.04M
121.92%44.53M
Free cash flow
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
-99.17%-3.54M
-61.08%-12.48M
-70.91%-3.33M
13.67%-4.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022(Q3)Apr 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M-99.17%-3.54M-61.08%-12.48M-70.91%-3.33M13.67%-4.82M
Net income from continuing operations 4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K-439.55%-10.02M
Operating gains losses -79.21%1.59M-246.84%-14.28M-118.18%-2.12M-7.73%-5.09M-109.10%-539.43K151.56%7.63M-116.31%-4.12M159.72%11.66M-138.48%-4.73M--5.93M
Depreciation and amortization 0.05%3.82K0.00%3.82K-0.01%15.27K-0.03%3.82K0.03%3.82K-0.05%3.82K0.03%3.82K0.10%15.27K0.16%3.82K0.08%3.82K
Other non cash items -----------------------------100.13%-2.41K--0--0
Change In working capital 6,070.75%1.84M-68.15%180.33K-802.65%-3.53M-507.17%-3.95M88.66%-181.88K-88.77%29.86K2,664.38%566.19K82.85%-391.29K1,481.25%969.16K40.92%-1.6M
-Change in receivables -142.06%-8.74K54.66%-2.54K145.36%5.23K58.45%-3.98K-147.24%-5.97K365.02%20.77K17.17%-5.6K-215.98%-11.53K-396.71%-9.57K215.15%12.63K
-Change in prepaid assets -428.26%-1.03M74.05%937.82K-475.56%-4.4M-1,179.51%-4.36M35.52%-888.59K212.99%312.73K389.37%538.82K-656.61%-764.05K-24.66%403.94K-116.29%-1.38M
-Change in payables and accrued expense 1,047.78%2.88M-2,390.30%-754.95K123.88%860.37K-27.22%418.36K398.37%712.68K-274.72%-303.64K126.28%32.96K117.54%384.29K220.23%574.8K88.44%-238.86K
Cash from discontinued investing activities
Operating cash flow -87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M-99.17%-3.54M-61.08%-12.48M-70.91%-3.33M13.67%-4.82M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 00205.65%3.95M2,603.40%4M-99.88%1.59K0-47.29K-105.76%-3.74M-100.42%-159.78K-94.83%1.37M
Net common stock issuance --0--0138.86%3.95M3,996.09%4M--0--0---47.29K-119.70%-10.17M-100.47%-102.67K-100.04%-12.79K
Proceeds from stock option exercised by employees ---------99.98%1.59K--0-------------52.50%6.51M--01,801.30%1.38M
Net other financing activities -------------------------------80.69K---57.12K--0
Cash from discontinued financing activities
Financing cash flow --0--0205.65%3.95M2,603.40%4M-99.88%1.59K--0---47.29K-105.76%-3.74M-100.42%-159.78K-94.83%1.37M
Net cash flow
Beginning cash position -63.56%13.65M-48.22%21.25M-28.33%41.04M-36.74%28.17M-30.18%33.5M-32.51%37.45M-28.33%41.04M269,412.38%57.27M121.92%44.53M805,908.48%47.98M
Current changes in cash -87.29%-7.4M-111.86%-7.61M-21.96%-19.79M-98.51%-6.92M-54.29%-5.33M47.37%-3.95M-101.83%-3.59M-128.35%-16.23M-109.59%-3.49M-116.55%-3.45M
End cash Position -81.36%6.24M-63.56%13.65M-48.22%21.25M-48.22%21.25M-36.74%28.17M-30.18%33.5M-32.51%37.45M-28.33%41.04M-28.33%41.04M121.92%44.53M
Free cash flow -87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M-99.17%-3.54M-61.08%-12.48M-70.91%-3.33M13.67%-4.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg